Drug interactions with botanical products

Herbal Supplements-Drug Interactions: Scientific and Regulatory Perspectives

Volumn , Issue , 2006, Pages 25-47

  Lam, Y W Francis ^a,b   Huang, Shiew Mei ^c   Hall, Stephen D ^d  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^c CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^d INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84866108181     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (83)

1. Eisenberg DM, Davis RB, Ettner SL, et al. Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey. JAMA 1998; 280:1569-1575.
2. Ernst E. Herbal medicine: where is the evidence? BMJ 2000; 321:395-396.
3. Fugh-Berman A. Herb-drug interactions. Lancet 2000; 355:134-138.
4. Kaufman DW, Kelly JP, Rosenberg L, Anderson TE, Mitchell AA. Recent patterns of medication use in the ambulatory adult population of the United States. JAMA 2002; 287:337-344.
5. Tsen LC, Segal S, Pothier M, Bader AM. Alternative medicine use in presurgical patients. Anesthesiology 2000; 93:148-151.
6. Hensrud DD, Engle DD, Scheitel SM. Underreporting the use of dietary supplements and nonprescription medications among patients undergoing a periodic health examinations. Mayo Clin Proc 1999; 74:443-447.
7. Eisenberg DM, Kessler RC, Foster C, Norlock FE, Calkins DR, Delbanco TL. Unconventional medicine in the United States. N Engl J Med 1993; 328: 246-252.
8. Chang ZG, Kennedy DT, Holdford DA, Small RE. Pharmacists’ knowledge and attitudes toward herbal medicine. Ann Pharmacother 2000; 34:710-715.
9. Wang J, Xu R, Jin R, Chen Z, Fidler JM. Immunosuppressive activity of the Chinese medicinal plant Tripterygium wilfordi. I. Prolongation of rat cardiac and renal allograft survival by the PG27 extract and immunosuppressive synergy in combination therapy with cyclosporine. Transplantation 2000; 70: 447-455.
10. Zhu M, Wong PYK, Li RC. Effect of oral administration of fennel (Foeniculum vulgare) on ciprofloxacin absorption and disposition in the rat. J Pharm Pharmacol 1999; 51:1391-1396.
11. Mustapha A, Yakasai IA, Aguye IA. Effect of Tamarindus indica L. on the bioavailability of aspirin in healthy human volunteers. Eur J Drug Metab Pharmacokinet 1996; 21:223-226.
12. Juliano RL, Ling V. A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. Biochim Biophys Acta 1976; 455:152-162.
13. Van Asperen J, Van Tellingen O, Beijnen JH. The pharmacological role of P-glycoprotein in the intestinal epithelium. Pharmacol Res 1998; 37:429-435.
14. Ruschitzka F, Meier PJ, Turina M, Luscher TF, Noll G. Acute heart transplant rejection due to Saint John’s wort. Lancet 2000; 355(9203):548-549.
15. Kronbach T, Fischer V, Meyer UA. Cyclosporine metabolism in human liver: identification of a cytochrome P450III gene family as the major cyclosporine metabolizing enzyme explains interactions of cyclosporine with other drugs. Clin Pharmacol Ther 1988; 43:630-635.
16. Wacher VJ, Wu CY, Benet LZ. Overlapping substrate specificities and tissue distribution of cytochrome P450 3A and P-glycoprotein: implications for drug delivery and activity in cancer chemotherapy. Mol Carcinog 1995; 13:129-134.
17. Durr D, Stieger B, Kullak-Ublick GA, et al. St. John’s wort induces intestinal P-glycoprotein/MDR1 and intestinal and hepatic CYP3A4. Clin Pharmacol Ther 2000; 68:598-604.
18. Lown KS, Mayo RR, Leichtman AB, et al. Role of intestinal P-glycoprotein (mdr1) in interpatient variation in the oral bioavailability of cyclosporine. Clin Pharmacol Ther 1997; 62:248-260.
19. Johne A, Brockmoller J, Bauer S, Maurer A, Langheinrich M, Roots I. Pharmacokinetic interaction of digoxin with an herbal extract from St. John’s wort (Hypericum perforatum). Clin Pharmacol Ther 1999; 66:338-345.
20. Fromm MF, Kim RB, Stein CM, Wilkinson GR, Roden DM. Inhibition of p-glycoprotein-mediated drug transport: a unifying mechanism to explain the interaction between digoxin and quinidine. Circulation 1999; 99:552-557.
21. Wang Z, Gorski JC, Hamman MA, Huang SM, Lesko LJ, Hall SD. The effects of St. John’s wort (Hypericum perforatum) on human cytochrome P450 activity. Clin Pharmacol Ther 2001; 70:317-326.
22. Wang Z, Hamman MA, Huang SM, Lesko LJ, Hall SD. Effect of St. John’s wort on the pharmacokinetics of fexofenadine. Clin Pharmacol Ther 2002; 71: 414-420.
23. Moore LB, Goodwin B, Jones SA, et al. St. John’s wort induces hepatic drug metabolism through activation of the pregnane X receptor. Proc Natl Acad Sci USA 2000; 97:7500-7502.
24. Huang MT, Ho CT, Wang ZY, et al. Inhibition of skin tumorigenesis by rosemary and its constituents carnosal and ursolic acid. Cancer Res 1994; 54:701-708.
25. Plouzek CA, Ciolino HP, Clarke R, Yeh GC. Inhibition of P-glycoprotein activity and reversal of multidrug resistance in vitro by rosemary extract. Eur J Cancer 1999; 35:1541-1545.
26. Jodoin J, Demeule M, Beliveau R. Inhibition of the multidrug resistance P-glycoprotein activity by green tea polyphenols. Biochem Biophys Acta 2002; 1542:149-159.
27. Sadzuka Y, Sugiyama T, Sonobe T. Efficacies of tea components on doxorubicin induced antitumor activity and reversal of multidrug resistance. Toxicol Lett 2000; 114:155-162.
28. Zhou S, Koh H-L, Gao Y, Gong Z-Y, Lee EJD. Herbal bioactivation. Life Sci 2004; 74:935-968.
29. Greenblatt DJ, von Moltke LL, Harmatz JS, et al. Time course of recovery of cytochrome P450 3A function after single doses of grapefruit juice. Clin Pharmacol Ther 2003; 74:121-129.
30. Roby CA, Anderson GD, Kantor E, Dryer DA, Burstein AH. St. John’s wort: effect on CYP3A4 activity. Clin Pharmacol Ther 2000; 67:451-457.
31. Piscitelli SC, Burstein AH, Chaitt D, Alfaro RM, Falloon J. Indinavir concentrations and St. John’s wort. Lancet 2000; 355:547-548.
32. Hall SD, Wang Z, Huang SM, et al. The interaction between St. John’s wort and an oral contraceptive. Clin Pharmacol Ther 2003; 74:525-535.
33. Ernst E. Second thoughts about the safety of St. John’s wort. Lancet 1999; 354:2014-2016.
34. Rey JM, Walter G. Hypericum perforatum (St. John’s wort) in depression: pest or blessing? Med J Aust 1998; 169:583-586.
35. Rosenberg M, Waugh M. Oral contraceptive discontinuance: a prospective evaluation of frequency and reasons. Am J Obstet Gynecol 1998; 179:577-582.
36. Schwartz U, Bschel B, Kirch W. Unwanted pregnancy on self-medication with St. John’s wort despite hormonal contraception. Br J Clin Pharmacol 2003; 55:112-113.
37. Foster BC, Foster MS, Vandenhoek S, et al. An in vitro evaluation of human cytochrome P450-3A4 and P-glycoprotein inhibition by garlic. J Pharm Pharmaceut Sci 2001; 4:176-184.
38. Dalvi RR. Alteration in hepatic phase I and phase II biotransformation enzymes by garlic oil in rats. Toxicol Lett 1992; 60:299-305.
39. Gurley BJ, Gardner SF, Hubbard MA, et al. Cytochrome P450 phenotypic ratios for predicting herb-drug interactions in humans. Clin Pharmacol Ther 2002; 72:276-287.
40. Lin MC, Wang EJ, Patten C, et al. Protective effect of diallyl sulfone against acetaminophen-induced hepatotoxicity in mice. J Biochem Toxicol 1996; 11: 11-20.
41. Piscitelli SC, Burstein AH, Welden N, Gallicano KD, Falloon J. The effect of garlic supplements on the pharmacokinetics of saquinavir. Clin Infect Dis 2002; 34:234-238.
42. Gorski JC, Huang SM, Pinto A, et al. The effect of Echinacea (Echinacea purpurea root) on cytochrome P450 activity in vivo. Clin Pharmacol Ther 2004; 75:89-100.
43. Markowitz JS, Donovan JL, DeVane CL, et al. Multiple doses of Saw Palmetto (Serenoa repens) did not alter cytochrome P450 2D6 and 3A4 activity in normal volunteers. Clin Pharmacol Ther 2003; 74:536-542.
44. Dresser GK, Wacher V, Wong S, Wong HT, Bailey DG. Evaluation of peppermint oil and ascorbyl palmitate as inhibitors of cytochrome P4503A4 activity in vitro and in vivo. Clin Pharmacol Ther 2002; 72:247-255.
45. Yue QY, Jansson K. Herbal drug Curbicin and anticoagulant effect with and without warfarin: possibly related to the vitamin E component. J Am Geriatr Soc 2001; 49:838.
46. Cheema P, El-Mefty O, Jazieh AR. Intraoperative hemorrhage associated with the use of extract of Saw Palmetto herb: a case report and review of literature. J Intern Med 2001; 250:167-169.
47. Brue W, Hagenlocer M, Redl K, Tittel G, Stadler F, Wagner H. Antiinflammatory activity of sabal fruit extracts prepared with supercritical carbon dioxide. In vitro antagonists of cyclooxygenase and 5-lipoxygenase metabolism. Arzneimittel Forsch 1992; 42:547-551.
48. Pyevich D, Bogenschutz MP. Herbal diuretics and lithium toxicity. Am J Psychiatr 2001; 158:1329.
49. Gordon JB. SSRIs and St. John’s wort: possible toxicity? Am Fam Physician 1998; 57:950, 953.
50. Legnani C, Frascaro M, Guazzaloca G, Ludovici S, Cesarano G, Coccheri G. Effects of a dried garlic preparation on fibrinolysis and platelet aggregation in healthy subjects. Arzneimittel Forsch 1993; 43:119-122.
51. Rose KD, Croissant PD, Parliament CF, Levin MB. Spontaneous spinal epidural hematoma with associated platelet dysfunction from excessive garlic ingestion: a case report. Neurosurgery 1990; 26:880-882.
52. Burham BE. Garlic as a possible risk for postoperative bleeding. Plast Reconstr Surg 1995; 95:213.
53. German K, Kumar U, Blackford HN. Garlic and the risk of TURP bleeding. Br J Urol 1995; 76:518.
54. Matthews MK Jr. Association of Ginkgo biloba with intracerebral hemorrhage. Neurology 1998; 50:1933-1934.
55. Mohutsky MA, Elmer GW. Inhibition of cytochrome P450 in vitro by the herbal product Ginkgo biloba. Paper presented at the 41st Annual Meeting of the American Society of Pharmacognosy, Seattle, WA, 2000.
56. Page RL II, Lawerence JD. Potentiation of warfarin by dong quai. Pharmacotherapy 1999; 19:870-878.
57. Rosenblatt M, Mindel J. Spontaneous hyphema associated with ingestion of Ginkgo biloba extract. N Engl J Med 1997; 338:1108.
58. Barbenel DM, Yusufi B, O’Shea D, Bench CJ. Mania in a patient receiving testosterone replacement postorchidectomy taking St. John’s wort and sertraline. J Psychopharmacol 2000; 14:84-86.
59. Almeida JC, Grimsley EW. Coma from the health food store: interaction between kava and alprazolam. Ann Intern Med 1996; 125:940-941.
60. Matthews JM, Etheridge AS, Black SR. Inhibition of human cytochrome P450 activities by kava extract and kavalactones. Drug Metab Dispos 2002; 30: 1153-1157.
61. Zou L, Harkey MR, Henderson GL. Effects of herbal components on cDNAexpressed cytochrome P450 enzyme catalytic activity. Life Sci 2002; 71: 1579-1589.
62. Theoharides TC. Sudden death of a healthy college student related to ephedrine toxicity from a ma huang containing drink. J Clin Psychopharmacol 1997; 17: 437-439.
63. Haller CA, Benowitz NL. Adverse cardiovascular and central nervous system events associated with dietary supplements containing ephedra alkaloids. N Engl J Med 2000; 343:1833-1838.
64. Final rule declaring dietary supplements containing ephedrine alkaloids adulterated because they present an unreasonable risk. Federal Register 2004; 69:6787-6854.
65. Galluzi S, Zanetti O, Binetti G, Trabucchi M, Frisoni GB. Coma in a patient with Alzheimer’s disease taking low dose trazodone and Gingko biloba. J Neurol Neurosurg Psychiatr 2000; 68:679-680.
66. Sasaki K, Hatta S, Haga M, Ohshika H. Effects of bilobalide on gammaaminobutyric acid levels and glutamic acid decarboxylase in mouse brain. Eur J Pharmacol 1999; 367:165-173.
67. Rotzinger S, Fang J, Baker GB. Trazodone is metabolized to m-chlorophenylpiperazine by CYP3A4 from human sources. Drug Metab Dispos 1988; 26: 572-575.
68. Chow L, Johnson M, Wells A, Dasgupta A. Effect of the traditional Chinesemedicines Chan Su, Lu-Shen-Wan, Dan Shen, and Asian Ginseng on serum digoxin measurement by Tina-quant (Roche) and Synchron LX system (Beckman) digoxin immunoassays. J Clin Lab Anal 2003; 17:22-27.
69. McRae S. Elevated serum digoxin levels in a patient taking digoxin and Siberian ginseng. Can Med Assoc J 1996; 155:293-295.
70. Aslam M, Stockley IH. Interaction between curry ingredient (karela) and drug (chlorpropamide). Lancet 1979; 313(8116):607.
71. Spigset O. Reduced effect of warfarin caused by ubidecarenone. Lancet 1994; 344:1372-1373.
72. 10-enzyme systems. Res Commun Chem Pathol Pharmacol 1976; 13:109-114.
73. Dandekar UP, Chandra RS, Dalvi SS, et al. Analysis of clinically important interaction between phenytoin and shankhapushpi, an ayurvedic preparation. J Ethnopharmacol 1992; 35:285-288.
74. Rininger JA, Kickner S, Chigurupati P, Mclean A, Franck Z. Immunopharmacological activity of Echinacea preparations following simulated digestion on murine macrophages and human peripheral blood mononuclear cells. J Leukocyte Biol 2000; 68:503-510.
75. Piscitelli SC, Formentini E, Burstein AH, Alfaro R, Jagannatha S, Falloon J. Effect of milk thistle on the pharmacokinetics of indinavir in healthy volunteers. Pharmacotherapy 2002; 22:551-556.
76. DiCenzo R, Shelton M, Jordan K, et al. Coadministration of milk thistle and indinavir in healthy subjects. Pharmacotherapy 2003; 23:866-870.
77. Borek C. Garlic supplements and saquinavir. Clin Infect Dis 2002; 35:343.
78. Gilroy CM, Steiner JF, Byers T, Shapiro H, Georgian W. Echinacea and truth in labeling. Arch Intern Med 2003; 163:699-704.
79. Ginseng: Much ado about nothing? Consumer Reports, Nov. 1995; 699.
80. Obach RS. Inhibition of human cytochrome P450 enzymes by constituents of St. John’s wort’s, an herbal preparation used in the treatment of depression. J Pharmacol Expl Ther 2000; 294:88-95.
81. Budzinski JW, Foster BC, Vandenhoek S, Amason JT. An in vitro evaluation of human cytochrome P450 3A4 inhibition by selected commercial herbal extracts and tinctures. Phytomedicine 2000; 7:273-282.
82. Dresser GK, Schwartz UI, Wilkinson GR, Kim RB. Coordinate induction of both cytochrome P4503A and MDR1 by St. John’s wort in healthy subjects. Clin Pharmacol Ther 2003; 73:41-50.
83. Greenblatt DJ, von Moltke LL, Daily JP, Harmatz JS, Shader RI. Extensive impairment of triazolam and alprazolam clearance by short-term low dose ritonavir: the clinical dilemma of concurrent inhibition and induction. J Clin Psychopharmacol 1999; 19:293-296.